Search - tctmd.com

Displaying 101 - 120 of 378

Sort: Relevancy | Date

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News ACC 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Yael L. Maxwell

March 07, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Daily News

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Michael O'Riordan

February 22, 2023

News Daily News

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Yael L. Maxwell

February 21, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Conference News ISC 2023

Cilostazol, Isosorbide Mononitrate May Help After Lacunar Stroke: LACI-2

Todd Neale

February 10, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Myocarditis After COVID-19 Vaccination Less Serious Than Prepandemic Cases

Todd Neale

December 06, 2022

News Daily News

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

Todd Neale

November 23, 2022

News Conference News AHA 2022

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

Michael O'Riordan

November 10, 2022

Advertisement

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

Only Half of Revascularized PAD Patients Receive GDMT

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

Cilostazol, Isosorbide Mononitrate May Help After Lacunar Stroke: LACI-2

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Myocarditis After COVID-19 Vaccination Less Serious Than Prepandemic Cases

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content